Miami, FL 的 克隆氏症 臨床試驗
19 項針對 克隆氏症 的研究正在 Miami（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Research Associates of South Florida /ID# 280929, Miami
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Sanchez Clinical Research ( Site 5144), Miami
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- Gastro Health Research - Miami, Miami
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- A Plus Research /ID# 265878, Miami
- Sanchez Clinical Research /ID# 265887, Miami
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
招募中2/3 期
- Sanchez Clinical Research, Inc, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
招募中
- University of Miami, Miami
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Regis Clinical Research, LLC-Site Number: 8400041, Miami
- Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami-Site Number: 8400111, Miami
- 還有 4 項
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- Gastro Health Research - Miami, Miami
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
招募中2 期
- Bioresearch Partner-Kendale Lakes, Miami
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Gastro Health Research - Miami, Miami
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Sanchez Clinical Research, Inc, Miami
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
招募中觀察性研究
- University of Miami, Miami
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
招募中2 期
- Research Associates of South Florida, LLC, Miami
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
招募中4 期
- University of Miami, Miami
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
招募中2 期
- Investigational Site Number 8400028, Miami
- Investigational Site Number: 8400012, Miami
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Boston, MA19 項研究
- Cleveland, OH19 項研究
- St. Louis, MO19 項研究
- Tyler, TX17 項研究
- Orlando, FL17 項研究
- Houston, TX17 項研究
- Atlanta, GA17 項研究
- San Antonio, TX15 項研究
- Los Angeles, CA15 項研究
- San Diego, CA15 項研究
- Colorado Springs, CO13 項研究
Miami 的其他研究
- 乳癌42 項研究
- 癌症（所有類型）36 項研究
- 非小細胞肺癌31 項研究
- 前列腺癌27 項研究
- 肥胖症27 項研究
- 急性髓系白血病24 項研究
- 轉移性癌症23 項研究
- 過重23 項研究
- 卵巢癌23 項研究
- 潰瘍性結腸炎21 項研究
- 多發性骨髓瘤21 項研究
- 阿茲海默症20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。